The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Symbiotic-GI-03: A randomized, double-blind, phase 3 study of first-line PF-08634404, a PD-1/VEGF bispecific antibody, in combination with mFOLFOX6 in patients with metastatic colorectal cancer (mCRC).
 
Cathy Eng
Consulting or Advisory Role - Abbvie; Abbvie; Agenus; Amgen (I); Boehringer Ingelheim; Bristol Myers Squibb Foundation; EMD Serono; Gilead Sciences; GlaxoSmithKline; Incyte; Merck; Merus; Pfizer; Revolution Medicines; Taiho Oncology (I); Takeda
Research Funding - Gritstone Bio (Inst); Hutchison MediPharma (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Sumitomo Dainippon Pharma Oncology (Inst)
Travel, Accommodations, Expenses - Takeda
 
Elena Elez
Honoraria - Agenus; Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; GlaxoSmithKline; Janssen; Johnson&Johnson; Lilly; Medscape; Merck; Merck Serono; MSD; Nordic Group BV; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Rottapharm Biotech; Sanofi; Seagan; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Bayer; Boehringer Ingelheim; Bristol Myers Squibb; Cure Teq AG; GlaxoSmithKline; Janssen; Johnson&Johnson; Lilly; Medscape; Merck; Merck Serono; MSD; Nordic Group BV; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics Inc.; RIN Institute Inc.; Roche; Rottapharm Biotech; Sanofi; Seagan (Inst); SERVIER; Takeda
Speakers' Bureau - Agenus; Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; GlaxoSmithKline; Janssen; Johnson & Johnson; Lilly; Medscape; Merck; Merck Serono; MSD; Nordic Group BV; Novartis; Pfizer; Pierre Fabre; Repare Therapeutics; RIN Institute; Roche; Rottapharm Biotech; Sanofi; Seagan (Inst); SERVIER; Takeda
Research Funding - 1Globe Health Institute (Inst); Agenus (Inst); Amgen (Inst); Artios (Inst); AstraZeneca (Inst); Biontech Rna Pharmaceuticals Gmbh (Inst); Biontech Small Molecules Gmbh (Inst); Bristol-Myers Squibb International Corporation (Bms) (Inst); Cancer Research UK (Inst); Exelixis (Inst); Fédération Francophone De Cancérologie Digestive (Inst); Fundación CRIS Contra el Cáncer (Inst); GlaxoSmithKline (Inst); Grupo de Tratamiento de los Tumores Digestivos (TTD) (Inst); Grupo Español Multidisciplinar en Cáncer Digestivo (GEMCAD) (Inst); INCLIVA Institut d'Investigació Sanitària (Inst); InhibRx (Inst); Instituto de Salud Carlos III (ISCIII) (Inst); Istituto Fondazione AIRC di Oncologia Molecolare (IFOM) (Inst); Janssen Research & Development (Inst); Janssen-Cilag SA (Inst); Merck (Inst); Merck, Sharp & Dohme de España SA (Inst); Msd Regional Business Support Center Gmbh (Inst); Nouscom (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Agenus; Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Cure Teq AG; GlaxoSmithKline; Janssen; Johnson&Johnson; Lilly; Medscape; Merck; Merck Serono; MSD; Nordic Group BV; Novartis; Pfizer; Pierre fabre; Repare Therapeutics; RIN Institute Inc.; Roche; Rottapharm Biotech; Sanofi; Seagan; SERVIER; Takeda
 
Julien Taieb
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; BMS; Boehringer Ingelheim; Brenus Pharma; Merck KGaA; MSD; natera; Novartis; Oxford BioTherapeutics; Pierre Fabre; PROSKOPE; sanofi; SERVIER; takeda
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Rui- Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical
 
Hiroya Taniguchi
Honoraria - Ono Yakuhin; Taiho Pharmaceutical; Takeda
Research Funding - Daiichi Sankyo (Inst)
 
Tanios Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Jeanne Tie
Honoraria - Merck Serono; MSD Oncology
Consulting or Advisory Role - Arcus Biosciences (Inst); BeiGene; BMS; Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Haystack Oncology; MSD Oncology; Pierre Fabre; Roche; Takeda
Speakers' Bureau - MSD Oncology
Research Funding - Grail (Inst); Haystack Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Pierre Fabre
 
Myriam Chalabi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); MSD (Inst); Roche/Genentech
Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Zhiyu Chen
No Relationships to Disclose
 
Aman Opneja
Consulting or Advisory Role - Pfizer; Taiho Oncology
 
Mark Kochenderfer
No Relationships to Disclose
 
Yong Sang Hong
No Relationships to Disclose
 
Donald Richards
Consulting or Advisory Role - Grail; Ipsen; Mirati Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Taiho Pharmaceutical
 
Barbara Radecka
Honoraria - Amgen; AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Gilead Sciences; Janssen; Johnson & Johnson; Lilly; Menarini; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Gilead Sciences; Janssen; Johnson & Johnson; Lilly; Menarini; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER; Swixx BioPharma; Takeda
Speakers' Bureau - Amgen; AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Gilead Sciences; Janssen; Johnson & Johnson; Lilly; Menarini; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Gilead Sciences; Janssen; Johnson & Johnson; Lilly; Menarini; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; SERVIER; Swixx BioPharma; Takeda
 
Yiyi Chen
Employment - Pfizer; Ultragenyx Pharmaceuticals (I)
Stock and Other Ownership Interests - Ultragenyx Pharmaceuticals (I)
 
Jill Clancy
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer
 
Svitlana Tonkovyd
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Xiaosong Zhang
Employment - Pfizer; Pfizer (I)
Stock and Other Ownership Interests - Pfizer; Pfizer (I)
Patents, Royalties, Other Intellectual Property - Patents in cancer genomics
Travel, Accommodations, Expenses - Pfizer; Pfizer
 
Kimmie Ng
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Abbvie; Agenus; Amgen; AstraZeneca; CytomX Therapeutics; Etiome; GlaxoSmithKline; Johnson & Johnson/Janssen; Manta Cares; Pfizer; Revolution Medicines; Sanofi; Sanofi
Research Funding - Janssen (Inst); Pharmavite (Inst)
Expert Testimony - Crico
Other Relationship - jama